IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 388 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $589,680 | +10.6% | 13,000 | 0.0% | 0.01% | +9.1% |
| Q2 2023 | $533,390 | +14.8% | 13,000 | 0.0% | 0.01% | +22.2% |
| Q1 2023 | $464,620 | +53.8% | 13,000 | +62.5% | 0.01% | +80.0% |
| Q4 2022 | $302,160 | -14.6% | 8,000 | 0.0% | 0.01% | -28.6% |
| Q3 2022 | $354,000 | +19.6% | 8,000 | 0.0% | 0.01% | +16.7% |
| Q2 2022 | $296,000 | 0.0% | 8,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $296,000 | +21.8% | 8,000 | 0.0% | 0.01% | +20.0% |
| Q4 2021 | $243,000 | -9.3% | 8,000 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $268,000 | -16.0% | 8,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $319,000 | -11.4% | 8,000 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $360,000 | -29.3% | 8,000 | -11.1% | 0.01% | -52.9% |
| Q4 2020 | $509,000 | -17.5% | 9,000 | -30.8% | 0.02% | -32.0% |
| Q3 2020 | $617,000 | -19.5% | 13,000 | 0.0% | 0.02% | -10.7% |
| Q2 2020 | $766,000 | +35.1% | 13,000 | +8.3% | 0.03% | +12.0% |
| Q1 2020 | $567,000 | -23.1% | 12,000 | -1.6% | 0.02% | +19.0% |
| Q4 2019 | $737,000 | +0.8% | 12,200 | 0.0% | 0.02% | -4.5% |
| Q3 2019 | $731,000 | -6.8% | 12,200 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $784,000 | -20.8% | 12,200 | 0.0% | 0.02% | -21.4% |
| Q1 2019 | $990,000 | – | 12,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |